NanoViricides Valuation
| NNVC Stock | USD 1.15 0.10 8.00% |
Today, the firm appears to be undervalued. NanoViricides secures a last-minute Real Value of $2.14 per share. The latest price of the firm is $1.15. Our model forecasts the value of NanoViricides from analyzing the firm fundamentals such as Current Valuation of 8.3 M, shares owned by insiders of 4.61 %, and Return On Equity of -0.58 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting NanoViricides' valuation include:
Price Book 1.1825 | Enterprise Value 8.3 M | Enterprise Value Ebitda (1.08) |
Undervalued
Today
Please note that NanoViricides' price fluctuation is very risky at this time. Calculation of the real value of NanoViricides is based on 3 months time horizon. Increasing NanoViricides' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for NanoViricides is useful when determining the fair value of the NanoViricides stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of NanoViricides. Since NanoViricides is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NanoViricides Stock. However, NanoViricides' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.15 | Real 2.14 | Target 5.25 | Hype 1.15 |
The real value of NanoViricides Stock, also known as its intrinsic value, is the underlying worth of NanoViricides Company, which is reflected in its stock price. It is based on NanoViricides' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of NanoViricides' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NanoViricides' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NanoViricides helps investors to forecast how NanoViricides stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NanoViricides more accurately as focusing exclusively on NanoViricides' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use NanoViricides' intrinsic value based on its ongoing forecasts of NanoViricides' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against NanoViricides' closest peers. When choosing an evaluation method for NanoViricides, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
NanoViricides Investments |
|
NanoViricides Valuation Trend
Knowing NanoViricides' actual value is paramount for traders to make sound investment determinations. NanoViricides' real value is not only important for the investor to make better decisions but also for a more accurate overall view of NanoViricides' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both NanoViricides' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
NanoViricides Market Cap
NanoViricides is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 907.87 Million. NanoViricides claims roughly 13.55 Million in market capitalization contributing just under 2% to equities under Health Care industry.NanoViricides Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining NanoViricides's current stock value. Our valuation model uses many indicators to compare NanoViricides value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NanoViricides competition to find correlations between indicators driving NanoViricides's intrinsic value. More Info.NanoViricides is regarded fourth in price to earning category among related companies. It is rated below average in price to book category among related companies . As of April 16, 2024, Price To Book Ratio is expected to decline to 0.77. Comparative valuation analysis is a catch-all model that can be used if you cannot value NanoViricides by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NanoViricides' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NanoViricides' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates NanoViricides' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in NanoViricides and how it compares across the competition.
About NanoViricides Valuation
The stock valuation mechanism determines the current worth of NanoViricides on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of NanoViricides. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of NanoViricides based exclusively on its fundamental and basic technical indicators. By analyzing NanoViricides's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of NanoViricides's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of NanoViricides. We calculate exposure to NanoViricides's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NanoViricides's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -672.8 K | -639.1 K | |
| Pretax Profit Margin | 0.00 | 0.00 | |
| Operating Profit Margin | 0.00 | 0.00 | |
| Net Profit Margin | 0.00 | 0.00 | |
| Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct NanoViricides' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates NanoViricides' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NanoViricides' valuation analysis, follow these 8 steps:- Gather financial information: Obtain NanoViricides' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine NanoViricides' revenue streams: Identify NanoViricides' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research NanoViricides' industry and market trends, including the size of the market, growth rate, and competition.
- Establish NanoViricides' growth potential: Evaluate NanoViricides' management, business model, and growth potential.
- Determine NanoViricides' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NanoViricides' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
NanoViricides Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as NanoViricides does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 11.6 M |
NanoViricides Current Valuation Indicators
Valuation refers to the process of determining the present value of NanoViricides and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NanoViricides we look at many different elements of the entity such as NanoViricides's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. NanoViricides' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final NanoViricides' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NanoViricides, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NanoViricides' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NanoViricides' worth.When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.